Physician profile
Sam Morhaim
NPI 1760606248
$1,512.28
in general payments reported to CMS, 2019-2025
9 companies · $407 in 2025
The $407 reported for 2025 was more than what 79% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $98.00 · 2021: $337 · 2022: $139 · 2023: $93.62 · 2024: $101 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $614.30 | 2020-2025 | |
| Keystone Dental INC. | $415.70 | 2019-2021 | |
| Neoss, INC. | $147.30 | 2021-2022 | |
| Dentsply Sirona INC | $117.72 | 2023-2025 | Cavitron, Nupro, Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive |
| Zimmer Biomet Holdings, INC. | $68.98 | 2019-2021 | |
| Nobel Biocare USA | $61.60 | 2023 | Nobelactive |
| Philips North America LLC | $37.02 | 2022-2025 | Whitening Pens |
| Orapharma, A Division of Bausch Health US, LLC | $34.55 | 2019-2024 | Ossix Plus |
| 3m Company | $15.11 | 2023 | Clarity Aligners |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Morhaim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.